TY - JOUR
KW - CPRD Aurum
KW - Cprd gold
KW - Database
KW - primary care
AU - J. Gulikers
AU - A. van Veelen
AU - J. Driessen
AU - P. Souverein
AU - V. Tjan-Heijnen
AU - L. Hendriks
AU - Rmjm van Geel
AU - S. Croes
AD - Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
CARIM School for Cardiovascular Disease, Maastricht University, Maastricht, The Netherlands.
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
NUTRIM, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Division Medical Oncology, GROW, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Department of Pulmonary Diseases, GROW, Maastricht University Medical Centre+, Maastricht, The Netherlands.
AN - 37309816
BT - Pharmacoepidemiol Drug Saf
DO - 10.1002/pds.5637
DP - NLM
ET - 2023/06/13
LA - eng
N1 - 1099-1557
Gulikers, J L
Orcid: 0000-0002-8844-6992
van Veelen, A J
Driessen, J H M
Souverein, P C
Tjan-Heijnen, V C G
Hendriks, L E L
van Geel, R M J M
Croes, S
None/
Journal Article
England
Pharmacoepidemiol Drug Saf. 2023 May 11. doi: 10.1002/pds.5637.
PY - 2023
SN - 1053-8569
T2 - Pharmacoepidemiol Drug Saf
TI - Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD
ER -